Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
- PMID: 26296089
- PMCID: PMC4546620
- DOI: 10.1371/journal.pone.0132754
Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
Abstract
Patients who have survived malignant melanoma for more than five years may lack the opportunity to talk about their burden. As a consequence their psychosocial care needs remain undetected and available supportive interventions may not be utilised. Therefore, the psychosocial burden of this patient group needs to be assessed using specific screening instruments. The aim of this study was to investigate the psychosocial burden of long-term melanoma survivors, their psychosocial care needs and the determinants of these needs. We wanted to find out if the use of professional support corresponds to the care needs defined by experts. Using the cancer registry of Rhineland-Palatinate, melanoma patients diagnosed at least 5 years before the survey were contacted by physicians. N = 689 former patients completed the Hornheide Questionnaire (short form HQ-S) to identify psychosocial support need (scale cut off ≥ 16 or item-based cut-off score) and the potential psychosocial determinants of these needs. Additionally, they were asked about their utilisation of the professional support system. More than one third (36%) of them was in need for professional psychosocial support. The highest burden scores concerned worry about tumour progression. Younger age (< 50), higher general fatigue, higher symptom burden, lower general health, negative social interactions and unfulfilled information needs were significant predictors of the need for psychosocial intervention. Related to the percentage of survivors identified as 'in need', the professional support system was underused. Further studies should investigate whether using the HQ-S to routinely identify burdened melanoma patients could lead to better fulfilment of their intervention needs, ultimately enhancing health-related quality of life.
Conflict of interest statement
Similar articles
-
Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.BMC Public Health. 2018 Apr 17;18(1):511. doi: 10.1186/s12889-018-5401-1. BMC Public Health. 2018. PMID: 29665805 Free PMC article.
-
Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.J Immunol Res. 2020 Jul 21;2020:2192480. doi: 10.1155/2020/2192480. eCollection 2020. J Immunol Res. 2020. PMID: 32775464 Free PMC article. Clinical Trial.
-
Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.PLoS One. 2015 Jan 23;10(1):e0116440. doi: 10.1371/journal.pone.0116440. eCollection 2015. PLoS One. 2015. PMID: 25615573 Free PMC article.
-
Long-term issues and supportive care needs of adolescent and young adult childhood brain tumour survivors and their caregivers: A systematic review.Psychooncology. 2019 Mar;28(3):477-487. doi: 10.1002/pon.4989. Epub 2019 Feb 1. Psychooncology. 2019. PMID: 30657618
-
Screening for reducing morbidity and mortality in malignant melanoma.Cochrane Database Syst Rev. 2019 Jun 3;6(6):CD012352. doi: 10.1002/14651858.CD012352.pub2. Cochrane Database Syst Rev. 2019. PMID: 31157404 Free PMC article.
Cited by
-
Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact.BMC Med Res Methodol. 2017 Nov 22;17(1):150. doi: 10.1186/s12874-017-0425-2. BMC Med Res Methodol. 2017. PMID: 29166870 Free PMC article.
-
Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.BMC Public Health. 2018 Apr 17;18(1):511. doi: 10.1186/s12889-018-5401-1. BMC Public Health. 2018. PMID: 29665805 Free PMC article.
-
Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads.Health Qual Life Outcomes. 2018 Aug 2;16(1):157. doi: 10.1186/s12955-018-0983-y. Health Qual Life Outcomes. 2018. PMID: 30068395 Free PMC article.
-
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors.J Oncol. 2019 Apr 28;2019:5269062. doi: 10.1155/2019/5269062. eCollection 2019. J Oncol. 2019. PMID: 31182961 Free PMC article. Review.
-
Digital Health in Melanoma Posttreatment Care in Rural and Remote Australia: Systematic Review.J Med Internet Res. 2018 Sep 24;20(9):e11547. doi: 10.2196/11547. J Med Internet Res. 2018. PMID: 30249578 Free PMC article.
References
-
- RKI, GEKID (2012) Krebs in Deutschland 2009/2010. Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V.: Berlin.
-
- Berking C. (2005) [The role of ultraviolet irradiation in malignant melanoma]. Hautarzt 56: 687–696. - PubMed
-
- Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ et al. (2004) Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol 22: 1118–1125. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous